Sermorelin
MODERATE EVIDENCEAlso known as: GRF 1-29
Previously approved for a specific indication; research supply is NOT an approved medicine
Educational Overview
A growth-hormone-releasing hormone analogue comprising the first 29 amino acids of GHRH. Historically used diagnostically before withdrawal from the US market for commercial reasons.
Research Mechanism
Stimulates pituitary GHRH receptors to promote endogenous growth hormone release — a comparatively well-characterised mechanism.
Areas of Study
- GH-axis diagnostics (historical clinical)
- GH signalling research
Safety Considerations
Research-supplied material is not an approved medicine. Not for human use. Research material only.
Frequently Asked Questions
Is this approved for human use?
No. This material is supplied for laboratory research use only by qualified businesses and institutions. It is not a medicine and is not for human or veterinary consumption.
Do you provide purity documentation?
Certificates of analysis are available to approved accounts. Contact our team for batch-specific documentation.
References
References pending editorial review
We publish citations only after a qualified reviewer has verified them against the primary literature. We do not list references we have not checked. (1 queued.)
Last reviewed: 2026-07-23 · Status: in_review · References verified by editorial review before publication.
Disclaimer: Educational only. Not medical advice, diagnosis, or treatment. For research and educational purposes. Consult a licensed medical professional.